This study is a multi-center, prospective, non-randomized, observational study. The objectives of this study are to confirm the clinical safety and efficacy of the SJM Epic valve.
This study is a multi-centered, multi-country, prospective, non-randomized, observational study, without concurrent or matched controls, conducted under a common protocol. Bayesian methods will be used for the design and analysis of this study. The Bayesian model will determine if the data for the valve configurations are poolable. Bayesian methods also provide a means of determining the appropriate stopping time for the study based on the amount of information generated. The objectives of this study are to confirm the clinical safety and efficacy of the SJM Epic Valve by establishing the following: * adverse effect rates * clinical status as indicated by NYHA functional classification * hemodynamic performance
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
761
Surgical replacement of a diseased, damaged, or malfunctioning native or prosthetic aortic and/or mitral heart valves
Adverse effect rates
Time frame: Ongoing
Clinical status as indicated by NYHA functional classification
Time frame: At required follow-up visits
Hemodynamic performance
Time frame: At required follow-up visits
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.